An indirubin derivative, E804, exhibits potent angiosuppressive activity

Biochemical Pharmacology

Volumn 83, Issue 5, 2012, Pages 598-607

  Chan, Yuk Kit ^a   Kwok, Hoi Hin ^a   Chan, Lai Sheung ^a   Leung, Kelvin Sze Yin ^a   Shi, Jue ^a   Mak, Nai Ki ^a   Wong, Ricky Ngok Shun ^a   Yue, Patrick Ying Kit ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Anti angiogenesis; E804; HUVEC; Indirubin 3 oxime

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; E 804; GELATINASE A; GELATINASE B; HEMOGLOBIN; INDIRUBIN; INDIRUBIN 3' OXIME; OXIME; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; ZEBRA FISH;

ANIMALS; AORTA; CELLS, CULTURED; EMBRYO, NONMAMMALIAN; ENDOTHELIAL CELLS; HUMANS; INDOLES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PATHOLOGIC; RATS; ZEBRAFISH;

EID: 84856092388     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.12.003     Document Type: Article

References (45)

1. J. Folkman, and S. Yuen Angiogenesis J Biol Chem 267 1992 10931 10934
2. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
3. W. Risau Mechanisms of angiogenesis Nature 386 1997 671 674 (Pubitemid 27193480)
4. D.A. Walsh Angiogenesis and arthritis Rheumatology 38 1999 103 112 (Pubitemid 29507229)
5. M.G. Tonnesen, X. Feng, and R.A. Clark Angiogenesis in wound healing J Investig Dermatol Symp Proc 5 2000 40 44
6. J. Favier, and P. Corvol Physiological angiogenesis Therapie 56 2001 455 463 (Pubitemid 34027017)
7. A. Hori, S. Ikeyama, and K. Sudo Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells Biochem Biophys Res Commun 204 1994 1067 1073 (Pubitemid 24367160)
8. L. Masiero, W.D. Figg, and E.C. Kohn New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12 Angiogenesis 1 1997 23 35 (Pubitemid 127505698)
9. E.C. Kohn Endostatin and angiostatin: the next anti-angiogenesis generation Angiogenesis 2 1998 25 27 (Pubitemid 128511969)
10. R. Han Highlight on the studies of anticancer drugs derived from plants in China Stem Cells 12 1994 53 63 (Pubitemid 24045786)
11. T. Kunikata, T. Tatefuji, H. Aga, K. Iwaki, M. Ikeda, and M. Kurimoto Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity Eur J Pharmacol 410 2000 93 100 (Pubitemid 32008134)
12. S. Jakobs, K.H. Merz, S. Vatter, and G. Eisenbrand Molecular targets of indirubins Int J Clin Pharmacol Ther 43 2005 592 594 (Pubitemid 43009362)
13. S. Nam, R. Buettner, J. Turkson, D. Kim, J.Q. Cheng, and S. Muehlbeyer Indirubin analogs inhibit Stat3 signaling and induce apoptosis in human cancer cells Proc Natl Acad Sci USA 102 2005 5998 6003 (Pubitemid 40594244)
14. L. Meijer, J. Shearer, K. Bettayeb, and Y. Ferandin Diversity of intracellular mechanisms underlying the anti-tumor properties of indirubins Indirubin, the Red Shade of Indigo 2006 Chapter 24, pp. 235-46
15. S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J.A. Bibb, and G.L. Snyder Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem 276 2001 251 260 (Pubitemid 32050314)
16. F.G. Perabo, G. Landwehrs, C. Frössler, D.H. Schmidt, and S.C. Mueller Antiproliferative and apoptosis inducing effects of indirubin-3′- monoxime in renal cell cancer cells Urol Oncol 29 2009 815 820
17. F.G. Perabo, C. Frössler, G. Landwehrs, D.H. Schmidt, A. von Rücker, and A. Wirger Indirubin-3′-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer Anticancer Res 26 2006 2129 2135 (Pubitemid 43989480)
18. R. Hoessel, S. Leclerc, J.A. Endicott, M.E. Nobel, A. Lawrie, and P. Tunnah Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases Nat Cell Biol 1 1999 60 67 (Pubitemid 129495012)
19. D. Marko, S. Schätzle, A. Friedel, A. Genzlinger, H. Zankl, and L. Meijer Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin analogs in human tumour cells Br J Cancer 84 2001 283 289 (Pubitemid 32113458)
20. Y. Zhen, V. Sørensen, Y. Jin, Z. Suo, and A. Wiedłocha Indirubin-3′-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK Oncogene 26 2007 6372 6385 (Pubitemid 47494224)
21. J.K. Kim, E.K. Shin, Y.H. Kang, and J.H. Park Indirubin-3′- monoxime, a analog of a chinese antileukemia medicine, inhibits angiogenesis J Cell Biochem 112 2011 1384 1391
22. S. Zahler, J. Liebl, R. Fürst, and A.M. Vollmar Anti-angiogenic potential of small molecular inhibitors of cyclin dependent kinases in vitro Angiogenesis 13 2010 239 249
23. X. Zhang, Y. Song, Y. Wu, Y. Dong, L. Lai, and J. Zhang Indirubin inhibits tumor growth by anti-tumor angiogenesis through blocking VEGFR2 mediated JAK/STAT3 signaling in endothelial cell Int J Cancer 129 2011 2502 2511
24. D. Alex, I.K. Lam, Z. Lin, and S.M. Lee Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model J Ethnopharmacol 131 2010 242 247
25. H.W. Lam, H.C. Lin, S.C. Lao, J.L. Gao, S.J. Hong, and C.W. Leong The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo J Cell Biochem 103 2008 195 211
26. H.H. Kwok, W.Y. Ng, M.S. Yang, N.K. Mak, R.N. Wong, and P.Y. Yue The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status Free Radic Biol Med 48 2010 437 445
27. P.Y. Yue, E.P. Leung, N.K. Mak, and R.N. Wong A simplified method for quantifying cell migration/wound healing in 96-well plates J Biomol Screen 15 2010 427 433
28. L.S. Chan, P.Y. Yue, N.K. Mak, and R.N. Wong Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis Eur J Pharm Sci 38 2009 370 377
29. P.Y. Yue, D.Y. Wong, P.K. Wu, P.Y. Leung, N.K. Mak, and H.W. Yeung The angiosuppressive effects of 20(R)-ginsenoside Rg3 Biochem Pharmacol 72 2006 437 445
30. P.Y. Yue, D.Y. Wong, W.Y. Ha, M.C. Fung, N.K. Mak, and H.W. Yeung Elucidation of the mechanisms underlying the angiogenic effects of ginsenoside Rg(1) in vivo and in vitro Angiogenesis 8 2005 205 216 (Pubitemid 41759145)
31. L. Guedez, A.M. Rivera, R. Salloum, M.L. Miller, J.J. Diegmueller, and P.M. Bungay Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay Am J Pathol 162 2003 1431 1439 (Pubitemid 36512825)
32. Z. Xiao, Y. Wang, L. Lu, Z. Li, Z. Peng, and Z. Han Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro Leuk Res 30 2006 54 59 (Pubitemid 41654705)
33. R. Heidenreich, M. Röcken, and K. Ghoreschi Angiogenesis drives psoriasis pathogenesis Int J Exp Pathol 90 2009 232 248
34. Y.K. Lin, Y.L. Leu, S.H. Yang, H.W. Chen, C.T. Wang, and J.H. Pang Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component J Dermatol Sci 54 2009 168 174
35. Y.K. Lin, C.J. Chang, Y.C. Chang, W.R. Wong, S.C. Chang, and J.H. Pang Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis Arch Dermatol 144 2008 1457 1464
36. R. Jautelat, T. Brumby, M. Schäfer, H. Briem, G. Eisenbrand, and S. Schwahn From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors Chembiochem 6 2005 531 540 (Pubitemid 40868142)
37. M.J. Moon, S.K. Lee, J.W. Lee, W.K. Song, S.W. Kim, and J.I. Kim Synthesis and structure-activity relationships of novel indirubin analogs as potent anti-proliferative agents with CDK2 inhibitory activities Bioorg Med Chem 14 2006 237 246 (Pubitemid 41635486)
38. G.S. Herron, M.J. Banda, E.J. Clark, J. Gavrilovic, and Z. Werb Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors J Biol Chem 261 1986 2814 2818 (Pubitemid 17218297)
39. L.A. Liotta Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture Cancer Res 46 1986 1 7 (Pubitemid 16189019)
40. J. Ribas, K. Bettayeb, Y. Ferandin, M. Knockaert, X. Garrofé- Ochoa, and F. Totzke 7-Bromoindirubin-3′-oxime induces caspase-independent cell death Oncogene 25 2006 6304 6318 (Pubitemid 44564746)
41. M. Knockaert, M. Blondel, S. Bach, M. Leost, C. Elbi, and G.L. Hager Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins Oncogene 23 2004 4400 4412 (Pubitemid 38850419)
42. X.Y. Deng, S.N. Zheng, G.H. Gao, G. Fan, and F. Li Determination and pharmacokinetic study of indirubin in rat plasma by high-performance liquid chromatography Phytomedicine 15 2008 277 283
43. G.M. Cragg, D.J. Newman, and K.M. Snader Natural products in drug discovery and development J Nat Prod 60 1997 52 60 (Pubitemid 27052102)
44. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years J Nat Prod 70 2007 461 477 (Pubitemid 46595760)
45. D.J. Newman, G.M. Cragg, and K.M. Snader Natural products as sources of new drugs over the period 1981-2002 J Nat Prod 66 2003 1022 1037 (Pubitemid 36909859)